Showing results (471-480 of 804) with videos related to

Sort By:
Pageof 81
The EMBO Journal|February 10, 2006
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancerJeroen R Mesters, Cyril Barinka, Weixing Li, et al.
The Journal of Pediatrics|January 1, 1995
Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infantsT M Slusher, H J Vreman, D W McLaren, et al.
AIDS (London, England)|February 27, 2024
Brain N -acetyl-aspartyl-glutamate is associated with cognitive function in older virally suppressed people with HIVRobyn L Wiseman, Kristin L Bigos, Raha M Dastgheyb, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2021
Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l-norleucine (DON) containing a diazo precursorRun-Duo Gao, Niyada Hin, Eva Prchalová, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1992
Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedureJ T Slusher, S K Kuwahara, F M Hamzeh, et al.
Sports Medicine - Open|October 6, 2015
Obesity-Related Oxidative Stress: the Impact of Physical Activity and Diet ManipulationChun-Jung Huang, Matthew J McAllister, Aaron L Slusher, et al.
The Journal of Clinical Investigation|May 24, 2008
FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in miceAdama Kamagate, Shen Qu, German Perdomo, et al.
Annals of Surgical Oncology|March 23, 2013
Intraperitoneal cytokine level in patients with peritoneal surface malignancies. A study of the RENAPE (French Network for Rare Peritoneal Malignancies)Virginie Vlaeminck-Guillem, Jacques Bienvenu, Sylvie Isaac, et al.
Advances in Pharmacology (San Diego, Calif.)|February 10, 2025
Neutral sphingomyelinase 2: A promising drug target for CNS diseaseMeixiang Huang, Matthew Stremlau, Jason Zavras, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 24, 2013
Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA)Rana Rais, Camilo Rojas, Krystyna Wozniak, et al.
Pageof 81